Hepatobiliary Flashcards

1
Q

What is Hepatocellular Carcinoma?

A
  • 6th most common cancer worldwide and third leading cause of cancer death.
  • Arise as a result of chronic inflammatory process affecting the liver.
  • Most commonly due to viral hepatitis but other common causes are chronic alcoholism, hereditary haemochromatosis, primary biliary cirrhosis and aflatoxin.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are risk factors for Hepatocellualar Carcinoma?

A
  • Viral Hepatitis (most common) – Hep B and Hep C commonly
  • High Alcohol intake
  • Smoking
  • Advanced age
  • Aflatoxin Exposure
  • Family history of liver disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are clinical features of HCC?

A
  • Symptoms of Liver Cirrhosis:
    • Fatigue
    • Fever
    • Weight Loss
    • Lethargy
    • Dull ache in the right upper abdomen
  • Advanced features show liver failure
    • Worsening ascites
    • Jaundice
  • Examination shows Irregular, Enlarged and Tender Liver
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are tests used to investigate HCC?

A
  • Laboratory Test
    • Liver function tests: ALP, ALT, AST, Bilirubin
      • If AST:ALT ratio >2, likely alcoholic liver disease
      • If AST:ALT around 1, likely viral hepatitis.
    • Low platelets or prolonged clotting with liver failure
    • Alpha fetoprotein levels
  • Imaging
    • Ultrasound is the initial imaging modality of choice.
    • If the mass >2cm is found with a raised AFP which is virtually diagnostic. Staging CT scan or MRI for further evaluation.
  • MRI scanning/contrast CT angiography may demonstrate a mass with arterial hypervascularisation; a characteristic feature of HCC.
    • If still in doubt, biopsy or PCI aspiration may be performed to confirm.Difficult in active ascites and/or deranged clotting
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How is HCC surgically managed?

A
  • Surgical Management
    • Surgical resection is treatment of choice in patient without cirrhosis and with a good baseline health status. 5-year recurrence of HCC post-resection occurs in 50-60%
  • Transplantation can be considered in patients that fulfil Milan Criteria:
    • One lesion is smaller than 5cm or three lesions are smaller than 3cm
    • There are no extrahepatic manifestations
    • There is no vascular infiltration
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How can HCC be non surgically managed?

A
  • Image-guided ablation: Indicated for patients with early HCC. Ultrasound probes are placed in the tumour mass to induce necrosis
  • Alcohol ablation: injection of alcohol into the tumour acting to destroy the malignant tissue.
  • Transarterial Chemoembolisation (TACE): High concentrations of chemotherapy drugs are radiologically injected directly into the hepatic artery and an embolising agent is then added to induce ischaemia.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the management of secondary HCC?

A
  • In most cases surgery more difficult and less useful option due to secondary site metastases. Oncological and Palliative services are often closely involved in the decision-making process
  • Surgery indicated in patient with metastases confined to liver who have their primary tumour under control.
    • Alternative are transarterial chemoembolization or selective internal radiotherapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Which cancers commonly metastasise to the liver?

A

Common cancer that metastasise to liver are

  • Bowel Cancer
  • Breast Cancer
  • Pancreas Cancer
  • Stomach Cancer
  • Lung Cancer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are some causes of Liver abscesses?

A
  • Cholecystitis
  • Cholangitis
  • Diverticulitis, Appendicitis
  • Septicaemia

Common isolated organisms are E. Coli, Staph. Aureus, K. Pneumoniae, S. Constellatus, and Fungus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are clinical features of Liver Abscesses?

A
  • Fever
  • Rigors
  • Abdominal Pain
  • Bloating
  • Nausea
  • Anorexia
  • Weight Loss
  • Fatigue
  • Jaundice
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are examination findings for Liver Abscesses?

A
  • RUQ tenderness +/- hepatomegaly.
  • If abscess ruptures, patient presents with signs of shock
  • Ruptured abscess shows pyrexia associated with Abdominal Pain or Bloating
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are some tests for investigation of Liver Abscesses?

A
  • Blood Tests: leucocytosis and abnormal with raised ALP in most cases. Deranged ALT and bilirubin in a proportion.
  • Blood Cultures and Fluid Cultures
  • Ultrasound: reveals poor-defied lesions with hypo- and hyper-echoic areas with potential gas bubbles and septation.
  • CT Imaging with Contrast: Reveals a similar pattern from the collection as seen on US with associated surrounding oedema
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the management of Liver Abscesses?

A
  • Fluid resuscitation and stabilisation.
  • Start on appropriate antibiotic therapy
    • Amoxicillin + Ciprofloxacin + Metranidazole
    • If penicillin allergic: Ciprofloxacin + Clindamycin
  • Most cases need draining via image-guided aspiration of the abscess either US or CT, for source control. Underlying cause should also be addressed
    • Surgery rarely indicated unless abscess as ruptured or refractory to antibiotic treatment

amoxicillin + ciprofloxacin + metronidazole

if penicillin allergic: ciprofloxacin + clindamycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What causes polycystic liver disease?

A

Characterised by presence of >20 cysts within the liver parenchyma each of which are >1cm in size. Caused by:

  • Autosomal Dominant Polycystic Kidney Disease which is caused by mutations in PDK1 and PKD2
  • Autosomal Dominant Polycystic Liver Disease (ADPLD) which is caused by mutations in PRKCSH (chromosome 19) or SEC63 (chromosome 6) genes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are clinical features of patient who present with Polycystic Liver Disease?

A
  • Abdominal pain as cysts grow
  • Hepatomegaly on examination

Can end in liver cirrhosis and portal hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are tests used to investigation of Polycystic Liver Disease?

A
  • Normal LFTs
  • Renal function can be affected.
  • Diagnosis can be via Ultrasound Imaging demonstrating multiple cysts.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are indications for surgery in Polycystic Liver Disease?

A
  • Intractable symptoms
  • Inability to rule out malignancy on imaging alone
  • Prevention malignancy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

How is Polycystic Liver Disease managed?

A
  • Asymptomatic cystic disease:
    • Monitored but many patients will require some form of intervention due to its progressive nature.
    • Somatostatin analogues in symptomatic relief
  • Symptomatic Disease
    • Laparoscopic de-roofing of cysts is preferred technique
    • Resection if particular liver segment are grossly affected
    • Transplantation may be warranted in extreme cases
    • US-guided aspiration may provide temporary relief in patients experiencing pain due to cyst size although this is not routinely performed due to recurrence
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

How is Bile Produced and Stored?

A
  • Bile is formed from cholesterol phospholipids and bile pigments. Stored in the gallbladder.
  • 3 main types of gallstones as a result of supersaturation of the bile:
    • Cholesterol stones: composed purely of cholesterol from excess cholesterol production. Poor diet linked
    • Pigment Stones: composed purely of bile pigments from excess bile pigments production. Commonly seen in those with known haemolytic anaemia
    • Mixed Stones: comprised of both cholesterol and bile pigments
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are risk factors for Biliary Colic and Cholecystitis?

A

5 F’s:

  • Fat
  • Female
  • Fertility
  • Forty
  • Family History
  • Others are pregnancy, oral contraceptives, haemolytic anaemia and malabsorption
    • Oestrogen causes more cholesterol to be secreted into bile
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are General features to look for in Gallbladder pathologies?

A
  • Signs of inflammation
    • Tachycardia
    • Pyrexia
  • Signs of peritonitis or peroration,
  • Signs of jaundice or hepatomegaly
    • Tender in RUQ and positive Murphy’s Sign (hook hand around the right costal margin and check for pain when asking patient to inspire)
22
Q

What are clinical features of Biliary Colic?

A
  • Right upper quadrant although may radiate to epigastrium and/or back
  • Pain precipitated by consumption of fatty foods
    • Fatty acids stimulate duodenum endocrine cells to release CCK to stimulate contract of the gallbladder
  • Nausea
  • Vomiting
23
Q

What are clinical features of Acute Cholecystitis?

A
  • Pain focused in the right upper quadrant although may radiate to epigastrium and/or back
  • Pain may be constant despite pain relief and is often associated with sign of inflammation (fever, raised WCC)
  • Derangement of their liver function tests
24
Q

What causes pain in Biliary Colic?

A

Neck occluded by gallstones therefore when there is contraction of the gallbladder against occluded neck resulting in sudden, dull and colicky pain.

25
Q

What are urinary tests and blood tests done for investigation of Gallstone pathology?

A
  • Urinalysis (including a pregnancy test if female) should be performed to exclude any renal and tubo-ovarian pathology.
  • Routine Blood Test
    • FBC and CRP – assess for presence of any inflammatory response which is raised in biliary pathology such as cholecystitis, cholangitis and pancreatitis
    • U&Es – assess for any dehydration, secondary to reduced oral fluid intake
    • LFTs – biliary colic and acute cholecystitis are likely to show a raised ALP yet other parameters should remain within normal ranges
    • Amylase – to check for pancreatitis
26
Q

What are imaging investigations for Gallstone pathology?

A
  • 1st Line: Trans-abdominal ultrasound.
    • 3 specific area visualised:
      • Presence of gallstones or sludge
      • Gallbladder wall thickness
      • Bile Duct dilatation
  • Gold standard is Magnetic Resonance Cholangiopancreatography (MRCP), if US inconclusive
    • MRCP can show potential defects in biliary tree caused by gallstone disease with sensitivity approaching 100.
  • ERCP diagnostic and offers management
27
Q

How is Biliary Colic managed?

A
  • Lifestyle factors
    • Low fat diet, Weight loss, Increasing exercise and Suitable analgesia at discharge
  • Initial management
    • Prescribe analgesia typically NSAIDs and PRN opioids along with an appropriate antiemetic.
  • Definitive Management
    • Elective laparoscopic cholecystectomy is warranted should be ideally offered within 6 weeks of first presentation
28
Q

How is Acute Cholecystitis managed?

A
  • Initial Management
    • Intravenous antibiotics: such as co-amoxiclav +/- metronidazole)
    • Fluid resuscitation therapy.
    • SEPSIS 6 if indicated
    • NG tube if patient vomiting and patient nil by mouth as an ultrasound is more sensitive in absence of bowel gas.
    • Simple analgesics with PRN opioids and anti-emetics
  • Definitive Management
    • Laparoscopic cholecystectomy indicated within 1 week but should be done ideally within 48 hours of presentation.
    • For those not fit for surgery and not responding to antibiotics, Percutaneous cholecystostomy can be performed to drain the infection. Patient advised regarding further lifestyle changes thereafter.
29
Q

What are complications as a result of Acute Cholecystitis?

A
  • Gallbladder Empyema
  • Chronic Cholecystitis
  • Bouveret’s Syndrome and Gallstone Ileus
  • Obstructive Jaundice
  • Ascending Cholangitis
  • Acute Pancreatitis
30
Q

What is Bouveret’s Syndrome and Gallstone Ileus and how is it investigated and managed?

A
  • Inflammation of the gallbladder can cause fistula to form between the gallbladder wall and the duodenum allowing gallstones to pass into the small bowel. Bowel obstruction can occur:
    • Bouveret’s Syndrome – stone impacts to cause duodenal obstruction
    • Gallstone Ileus – stone impacts to cause an obstruction at terminal ileum (narrowest part of the adult bowel)
  • Laparotomy and removal of the gallstone from small bowel, the enterotomy must be made proximal to the site of obstruction and not at the site of obstruction. The fistula between the gallbladder and duodenum should not be interfered with.
31
Q

What is Gallbladder empyema and how is it managed?

A
  • When the gallbladder is infected and an abscess forms within the gallbladder. Patients are typically septic. Associated with significant morbidity and mortality.
  • Similar clinical picture to acute cholecystitis.
    • Swinging fever, systemically unwell patient.
  • Diagnosed by with US scan +/- CT scan.
  • Treat is via laparoscopic cholecystectomy or percutaneous cholecystostomy if the patient in unfit for surgery
32
Q

What is Chronic Cholecystitis and how is it managed?

A
  • History of recurrent or untreated cholecystitis, which has led to chronic inflammation of the gallbladder wall.
  • May present with ongoing RUQ or epigastric pain associated with nausea and vomiting.
  • Diagnosed by CT scan.
  • Managed in uncomplicated cases via elective cholecystectomy.
  • Main complications are increased risk of gallbladder carcinoma and biliary-enteric fistula
33
Q

What is Ascending Cholangitis?

A
  • Infection of the biliary tracts that is associated with high mortality and morbidity when left untreated.
  • Caused by combination of biliary outflow obstruction and biliary infection.
  • During obstruction, stasis of the fluid combines with elevated intraluminal pressure allow the bacterial colonisation to become pathological
34
Q

What are the causes of Ascending Cholangitis?

A
  • Any condition that cases occlusion for the biliary tree has potential for cholangitis. Most common causes are:
    • Gallstones
    • ERCP
    • Cholangiocarcinoma
    • Rarer causes include pancreatitis, primary sclerosing cholangitis, ischaemic cholangiopathy, and parasitic infections.
  • Most common infective organisms in cholangitis are:
    • Escherichia Coli (27%),
    • Klebsiella species (16%)
    • Enterococcus (15%).
35
Q

What are clinical features of Ascending Cholangitis?

A
  • Right upper quadrant pain
  • Fever
  • Jaundice (when bilirubin >50 μmol/L)
  • Pruritus (itching), as a result of bile accumulation.

Past medical history may include gallstones, recent biliary tract instrumentation (i.e. ERCP/cholecystectomy), or previous cholangitis.

36
Q

What are examination findings of Ascending Cholangitis?

A
  • Examination:Pyrexia (90%), Rigors, Jaundice, Right upper quadrant tenderness, confusion, hypotension, and tachycardia may be present
    • Charcots Triad: Jaundice, Fever, and RUQ Pain
    • Reynold’s Pentad: Jaundice, Fever, and RUQ pain, Hypotension, and Confusion
37
Q

What are Blood tests and Imaging used in the diagnosis of Ascending Cholangitis?

A
  • Routine Bloods:
    • FBC (leucocytosis), LFTs (raised ALP +/- GGT and raised bilirubin for post hepatic jaundice picture)
    • Blood cultures done suspected case.
  • Imaging
    • Ultrasound scan of biliary tract will show bile dilation. Common bile duct diameter of more than 6mm suggests dilatation.
    • ERCP is gold standard: Both diagnostic and therapeutic. Endoscopists may require an MRCP prior to intervention.
38
Q

How is Ascending Cholangitis managed?

A
  • Immediate Management
    • SEPSIS 6 protocol
  • Definitive Management
    • 1st Line: ERCP, with or without sphincterotomy and stenting, should clear any obstruction.
    • 2nd Line: Percutaneous Transhepatic cholangiography (PTC)
  • Long-term management involve cholecystectomy if gallstones were the underlying cause. Other causes should be identified for management
39
Q

What are some complications of ERCP?

A
  • Repeated Cholangitis
  • Pancreatitis (in 3-5% of patients)
  • Bleeding (more common when a spincterotomy is performed)
  • Perforation (needs surgical intervention urgently
40
Q

What is the general prognosis of those with Ascending Cholangitis?

A
  • Mortality of cholangitis is around 5-10% in those who are given antibiotic therapy. Early ERCP and early antibiotic therapy have both been found to improve patient outcomes.
  • Factors which increase the mortality rate include delayed diagnosis, liver failure, cirrhosis, CKD, hypotension, female gender, and >50yrs.
41
Q

What is a Cholangiocarcinoma?

A
  • Cancer of the Biliary System. Can occur at any site along the biliary tree, although predominantly arises in the extrahepatic biliary system.
  • Most common site is the bifurcation of the right and left hepatic ducts (termed Klatskin tumours). Typically, slow-growing tumour that invade locally and metastasise to local lymph nodes, before spreading distally to the peritoneal cavity, lung and liver.
42
Q

What are histological findings for a Cholangiocarcinoma?

A
  • Adenocarcinomas (95%) arising from cholangiocytes within the biliary tree.
  • Squamous cell carcinomas
  • Sarcomas
  • Lymphomas
  • Small cell cancers.
43
Q

What are risk factors for a Cholangiocarcinoma?

A
  • Primary sclerosing cholangitis
  • Ulcerative colitis
  • Infective (Liver flukes, HIV, hepatitis virus)
  • Toxins (Chemicals in rubber and aircraft industry)
  • Congenital (Caroli’s disease, choledochal cyst)
  • Alcohol excess
  • Diabetes Mellitus
44
Q

What are clinical features of Cholangiocarcinomas?

A

Generally asymptomatic until a late stage in the disease. Symptoms can include:

  • Post-hepatic Jaundice
  • Pruritus
  • Pale Stools
  • Dark Urine
  • RUQ pain
  • Early Satiety
  • Weight Loss
  • Anorexia and Malaise.
45
Q

What are examination findings for Cholangiocarcinomas?

A
  • Jaundice and Cachexia is often evident.
  • Courvoisier’s law can be applied in clinical assessment and states that in the presence of Jaundice and an Enlarged or Palpable Gallbladder, malignancy of the biliary tree or pancreas should be strongly suspected as the cause is unlikely to be gallstones. Signs may be present if the obstructing tumour is distal to the cystic duct.
46
Q

What are blood tests for Cholangiocarcinomas?

A
  • Obstructive Jaundice
  • Elevated bilirubin
  • Raised ALP
  • Raised ɣGT
  • Tumour markers CEA and CA19-9 may also be elevated
47
Q

What are imaging tests for Cholangiocarcinomas?

A
  • Ultrasound scanning used to initially confirm an obstructive cause.
  • MRCP is the optimal imaging for diagnosing cholangiocarcinoma
  • ERCP may be used to demonstrate the site of obstruction and also has the ability to obtain samples for cytology/histology.
  • CT imaging used for staging
    • Staging is based on the TNM classification, with some variations depending on whether the tumour is intrahepatic, hilar, peri-hilar or distal.
  • Angiography may also be used in pre-operative planning to image the hepatic arteries or portal vein.
48
Q

How are Cholangiocarcinomas surgically managed?

A
  • Definitive Cure for cholangiocarcinoma is complete surgical resection.
  • Intrahepatic and Klatskin tumour resection: Partial hepatectomy and reconstruction of the biliary tree.
  • Patients with distal common duct tumours: Pancreaticoduodenectomy also known as a Whipple’s procedure.
49
Q

How are Cholangiocarcinomas medically managed?

A
  • Radiotherapy may be used as adjunct or neoadjunct therapy.
50
Q

What are paallitave methods to mange cholangiocarcnimaS?

A
  • Stenting
    • ERCP may be used to stent the bile duct and relieve obstructive symptoms. Self-expanding metal stents offer the best outcome.
  • Surgery
    • Surgical bypass procedures may be required if the obstruction cannot be relieved by stenting
  • Medical
    • Palliative radiotherapy may be used to prolong survival. A combination of chemotherapy agents (e.g. cisplatin and gemcitabine) may be added to slow tumour growth.
51
Q

What are some complications associated with Cholangiocarcinomas?

A
  • Risk of biliary tract sepsis is increased (due to the biliary obstruction).
  • Secondary biliary cirrhosis occurs in 10-20% of patients.
52
Q

What are features of Acalculous cholecystitis and how is it managed?

A
  • Patients with intercurrent illness (e.g. diabetes, organ failure)
  • Patient of systemically unwell
  • Gallbladder inflammation in absence of stones
  • High fever

If patient fit then cholecystectomy, if unfit then percutaneous cholecystostomy